TGFBR1 and myeloid sarcoma: Strikingly, it was found that the expression levels of TGFBR1 and IGF1R on CD45RA+ naive CD4+ T cells were significantly decreased in patients with MS (p = 0.041 and 0.012, respectively, an unpaired t test) (Fig. 8b, c).